Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Lynavoy |
|---|---|
| Manufacturer | GlaxoSmithKline GmbH & Co.KG |
| Prescription required | Yes |
Lynavoy tablets 60 x 40mg(linerixibat)
linerixibat
Description
Lynavoy tablets 60 x 40mg(linerixibat) is a medicine catalog record in the MediPriceHub database. Active ingredient: linerixibat. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: GlaxoSmithKline GmbH & Co.KG. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Pack information: 40 / 60. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
LYNAVOY is indicated for the treatment of cholestatic pruritus associated with primary biliary cholangitis (PBC) in adult patients. Limitations of Use Avoid use of LYNAVOY in patients with decompensated cirrhosis or those with prior or active hepatic decompensation events (e.g. variceal hemorrhage, ascites, hepatic encephalopathy) [see Use in Specific Populations , Clinical Pharmacology ] .How to Use
Use linerixibat under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: linerixibat. Pack size: 40 / 60. Pack unit: bottle. Manufacturer: GlaxoSmithKline GmbH & Co.KG. Origin country: United States. Source category: Medicine Library > Liver and Gallbladder Diseases > Cholestatic liver disease. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.